PTR-01

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePTR-01
Drug Alias NameCollagen 7 replacement therapy - Phoenix Tissue RepairRecombinant collagen VIISHP-608HGT-DEB001PTR-01 +[6] 
ClassificationBiologics
Mechanisms of ActionCollagen alpha-1(VII) chain replacements
TargetsCollagen
Therapy Area/IndicationsEpidermolysis Bullosa DystrophicaEpidermolysis Bullosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Southern California
China Registration ClassN/A

Develop Information

Active CompaniesBridgebio Pharma IncPhoenix Tissue Repair
Inactive CompaniesN/A
Active IndicationsEpidermolysis Bullosa DystrophicaEpidermolysis Bullosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A